Table of Contents 1 Study Coverage 1.1 Radiopharmaceuticals in Nuclear Medicine Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Product 1.4.2 Diagnostic Radiopharmaceuticals 1.4.3 Therapy Radiopharmaceuticals 1.4.4 Enriched Stable Isotopes 1.5 Market by End User 1.5.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by End User 1.5.2 Diagnostic Application 1.5.3 Therapeutic Application 1.5.4 Research 1.5.5 Pharmaceutical 1.5.6 Other 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size 2.1.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue 2014-2025 2.1.2 Global Radiopharmaceuticals in Nuclear Medicine Sales 2014-2025 2.2 Radiopharmaceuticals in Nuclear Medicine Growth Rate by Regions 2.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Regions 2.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers 3.1.1 Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers 3.1.2 Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Manufacturers 3.1.3 Global Radiopharmaceuticals in Nuclear Medicine Market Concentration Ratio (CR5 and HHI) 3.2 Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers 3.2.1 Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2014-2019) 3.2.2 Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2014-2019) 3.3 Radiopharmaceuticals in Nuclear Medicine Price by Manufacturers 3.4 Radiopharmaceuticals in Nuclear Medicine Manufacturing Base Distribution, Product Types 3.4.1 Radiopharmaceuticals in Nuclear Medicine Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Type 3.4.3 Date of International Manufacturers Enter into Radiopharmaceuticals in Nuclear Medicine Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Product 4.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Product 4.3 Radiopharmaceuticals in Nuclear Medicine Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Radiopharmaceuticals in Nuclear Medicine Breakdown Data by End User 6 North America 6.1 North America Radiopharmaceuticals in Nuclear Medicine by Countries 6.1.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Countries 6.1.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Radiopharmaceuticals in Nuclear Medicine by Product 6.3 North America Radiopharmaceuticals in Nuclear Medicine by End User 7 Europe 7.1 Europe Radiopharmaceuticals in Nuclear Medicine by Countries 7.1.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Countries 7.1.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Radiopharmaceuticals in Nuclear Medicine by Product 7.3 Europe Radiopharmaceuticals in Nuclear Medicine by End User 8 Asia Pacific 8.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine by Countries 8.1.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Countries 8.1.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine by Product 8.3 Asia Pacific Radiopharmaceuticals in Nuclear Medicine by End User 9 Central & South America 9.1 Central & South America Radiopharmaceuticals in Nuclear Medicine by Countries 9.1.1 Central & South America Radiopharmaceuticals in Nuclear Medicine Sales by Countries 9.1.2 Central & South America Radiopharmaceuticals in Nuclear Medicine Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Radiopharmaceuticals in Nuclear Medicine by Product 9.3 Central & South America Radiopharmaceuticals in Nuclear Medicine by End User 10 Middle East and Africa 10.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine by Countries 10.1.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Countries 10.1.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine by Product 10.3 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine by End User 11 Company Profiles 11.1 Bracco Imaging S.P.A. 11.1.1 Bracco Imaging S.P.A. Company Details 11.1.2 Company Business Overview 11.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Products Offered 11.1.5 Bracco Imaging S.P.A. Recent Development 11.2 Cambridge Isotope Laboratories, Inc. 11.2.1 Cambridge Isotope Laboratories, Inc. Company Details 11.2.2 Company Business Overview 11.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered 11.2.5 Cambridge Isotope Laboratories, Inc. Recent Development 11.3 Cardinal Health, Inc. 11.3.1 Cardinal Health, Inc. Company Details 11.3.2 Company Business Overview 11.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered 11.3.5 Cardinal Health, Inc. Recent Development 11.4 Covidien, Plc 11.4.1 Covidien, Plc Company Details 11.4.2 Company Business Overview 11.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Products Offered 11.4.5 Covidien, Plc Recent Development 11.5 Eczacibasi-Monrol 11.5.1 Eczacibasi-Monrol Company Details 11.5.2 Company Business Overview 11.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Products Offered 11.5.5 Eczacibasi-Monrol Recent Development 11.6 Fujifilm Holdings Corporation 11.6.1 Fujifilm Holdings Corporation Company Details 11.6.2 Company Business Overview 11.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Products Offered 11.6.5 Fujifilm Holdings Corporation Recent Development 11.7 GE Healthcare (Subsidiary Of General Electric Company) 11.7.1 GE Healthcare (Subsidiary Of General Electric Company) Company Details 11.7.2 Company Business Overview 11.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Products Offered 11.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development 11.8 IBA Group 11.8.1 IBA Group Company Details 11.8.2 Company Business Overview 11.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.8.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Products Offered 11.8.5 IBA Group Recent Development 11.9 Isotec, Inc. (Sigma-Aldrich) 11.9.1 Isotec, Inc. (Sigma-Aldrich) Company Details 11.9.2 Company Business Overview 11.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Products Offered 11.9.5 Isotec, Inc. (Sigma-Aldrich) Recent Development 11.10 Lantheus Medical Imaging, Inc. 11.10.1 Lantheus Medical Imaging, Inc. Company Details 11.10.2 Company Business Overview 11.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019) 11.10.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered 11.10.5 Lantheus Medical Imaging, Inc. Recent Development 11.11 Nordion, Inc. 11.12 Ntp Radioisotopes (Pty), Ltd. 11.13 Siemens Healthcare (Subsidiary Of Siemens AG) 11.14 Taiyo Nippon Sanso Corporation 11.15 Urenco Limited 11.16 Rotem Industries, Ltd., Inc. 11.17 Australian Nuclear Association And Technology Organization (ANSTO) 11.18 Board of Radiation And Isotope Technology (BRIT) 11.19 Institute of Atomic Energy Polatom Radioisotope Centre 11.20 Institute of Isotopes Co., Ltd. 11.21 Institute Of Radioelement (IRE) 12 Future Forecast 12.1 Radiopharmaceuticals in Nuclear Medicine Market Forecast by Regions 12.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Regions 2019-2025 12.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Regions 2019-2025 12.2 Radiopharmaceuticals in Nuclear Medicine Market Forecast by Product 12.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Product 2019-2025 12.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Product 2019-2025 12.3 Radiopharmaceuticals in Nuclear Medicine Market Forecast by End User 12.4 North America Radiopharmaceuticals in Nuclear Medicine Forecast 12.5 Europe Radiopharmaceuticals in Nuclear Medicine Forecast 12.6 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Forecast 12.7 Central & South America Radiopharmaceuticals in Nuclear Medicine Forecast 12.8 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Radiopharmaceuticals in Nuclear Medicine Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Radiopharmaceuticals in Nuclear Medicine Product Picture Table Radiopharmaceuticals in Nuclear Medicine Market Segments Table Key Manufacturers Radiopharmaceuticals in Nuclear Medicine Covered Table Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$) Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Product 2014-2025 Figure Diagnostic Radiopharmaceuticals Product Picture Table Major Manufacturers of Diagnostic Radiopharmaceuticals Figure Therapy Radiopharmaceuticals Product Picture Table Major Manufacturers of Therapy Radiopharmaceuticals Figure Enriched Stable Isotopes Product Picture Table Major Manufacturers of Enriched Stable Isotopes Table Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by End User 2019-2025 (K Units) Figure Diagnostic Application Figure Therapeutic Application Figure Research Figure Pharmaceutical Figure Other Figure Radiopharmaceuticals in Nuclear Medicine Report Years Considered Figure Global Radiopharmaceuticals in Nuclear Medicine Market Size 2014-2025 (Million US$) Figure Global Radiopharmaceuticals in Nuclear Medicine Sales 2014-2025 (K Units) Table Global Radiopharmaceuticals in Nuclear Medicine Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Radiopharmaceuticals in Nuclear Medicine Sales by Regions 2014-2019 (K Units) Table Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Regions 2014-2019 Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Regions 2014-2019 Figure 2018 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Regions Table Global Radiopharmaceuticals in Nuclear Medicine Revenue by Regions 2014-2019 (Million US$) Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Regions 2014-2019 Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Regions 2014-2019 Figure 2018 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Regions Table Global Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers (2014-2019) (K Units) Table Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Manufacturers (2014-2019) Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2014-2019) (Million USD) Table Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2014-2019) Figure Radiopharmaceuticals in Nuclear Medicine Value Share by Manufacturers in 2018 Table Key Manufacturers Radiopharmaceuticals in Nuclear Medicine Price (2014-2019) (USD/Unit) Table Radiopharmaceuticals in Nuclear Medicine Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Type Table Date of International Manufacturers Enter into Radiopharmaceuticals in Nuclear Medicine Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Radiopharmaceuticals in Nuclear Medicine Sales by Product (2014-2019) (K Units) Table Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Product (2014-2019) Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Product (2014-2019) Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Product in 2018 Table Global Radiopharmaceuticals in Nuclear Medicine Revenue by Product (2014-2019) (Million US$) Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Product (2014-2019) Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Product (2014-2019) Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Product in 2018 Table Radiopharmaceuticals in Nuclear Medicine Price by Product 2014-2019 (USD/Unit) Table Global Radiopharmaceuticals in Nuclear Medicine Sales by End User (2014-2019) (K Units) Table Global Radiopharmaceuticals in Nuclear Medicine Sales Share by End User (2014-2019) Figure Global Sales Radiopharmaceuticals in Nuclear Medicine Market Share by End User (2014-2019) Figure Global Sales Radiopharmaceuticals in Nuclear Medicine Market Share by End User in 2018 Figure North America Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2014-2019 (K Units) Figure North America Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2014-2019 (Million US$) Table North America Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2014-2019) (K Units) Table North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2014-2019) Figure 2018 North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries Table North America Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2014-2019) (Million US$) Table North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2014-2019) Figure 2018 North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure United States Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (K Units) Figure Canada Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure Canada Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure Mexico Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Table North America Radiopharmaceuticals in Nuclear Medicine Sales by Product (2014-2019) (K Units) Table North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Product (2014-2019) Figure 2018 North America Radiopharmaceuticals in Nuclear Medicine Market Share by Product Table North America Radiopharmaceuticals in Nuclear Medicine Sales by End User (2014-2019) (K Units) Table North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by End User (2014-2019) Figure 2018 North America Radiopharmaceuticals in Nuclear Medicine Market Share by End User Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2014-2019 (K Units) Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2014-2019 (Million US$) Table Europe Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2014-2019) (K Units) Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2014-2019) Figure 2018 Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2014-2019) (Million US$) Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries Figure Germany Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure Germany Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure France Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure France Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure UK Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure UK Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure Italy Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure Russia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Table Europe Radiopharmaceuticals in Nuclear Medicine Sales by Product (2014-2019) (K Units) Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Product (2014-2019) Figure 2018 Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Product Table Europe Radiopharmaceuticals in Nuclear Medicine Sales by End User (2014-2019) (K Units) Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by End User (2014-2019) Figure 2018 Europe Radiopharmaceuticals in Nuclear Medicine Market Share by End User Figure Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2014-2019) (K Units) Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries Figure China Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure China Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure Japan Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure Korea Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure India Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure India Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure Australia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure Indonesia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure Malaysia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure Philippines Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure Thailand Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure Vietnam Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure Singapore Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Product (2014-2019) (K Units) Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by Product Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by End User (2014-2019) (K Units) Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by End User Figure Central & South America Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2014-2019 (K Units) Figure Central & South America Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2014-2019) (K Units) Table Central & South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries Table Central & South America Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2014-2019) (Million US$) Table Central & South America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries Figure Brazil Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure Brazil Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure Argentina Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Radiopharmaceuticals in Nuclear Medicine Sales by Product (2014-2019) (K Units) Table Central & South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Radiopharmaceuticals in Nuclear Medicine Market Share by Product Table Central & South America Radiopharmaceuticals in Nuclear Medicine Sales by End User (2014-2019) (K Units) Table Central & South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Radiopharmaceuticals in Nuclear Medicine Market Share by End User Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2014-2019) (K Units) Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries Figure GCC Countries Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure Turkey Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure Egypt Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units) Figure South Africa Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Product (2014-2019) (K Units) Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Share by Product Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by End User (2014-2019) (K Units) Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Share by End User Table Bracco Imaging S.P.A. Company Details Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Bracco Imaging S.P.A. Recent Development Table Cambridge Isotope Laboratories, Inc. Company Details Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Cambridge Isotope Laboratories, Inc. Recent Development Table Cardinal Health, Inc. Company Details Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Cardinal Health, Inc. Recent Development Table Covidien, Plc Company Details Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Covidien, Plc Recent Development Table Eczacibasi-Monrol Company Details Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Eczacibasi-Monrol Recent Development Table Fujifilm Holdings Corporation Company Details Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Fujifilm Holdings Corporation Recent Development Table GE Healthcare (Subsidiary Of General Electric Company) Company Details Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table GE Healthcare (Subsidiary Of General Electric Company) Recent Development Table IBA Group Company Details Table IBA Group Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table IBA Group Recent Development Table Isotec, Inc. (Sigma-Aldrich) Company Details Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Isotec, Inc. (Sigma-Aldrich) Recent Development Table Lantheus Medical Imaging, Inc. Company Details Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Lantheus Medical Imaging, Inc. Recent Development Table Nordion, Inc. Company Details Table Ntp Radioisotopes (Pty), Ltd. Company Details Table Siemens Healthcare (Subsidiary Of Siemens AG) Company Details Table Taiyo Nippon Sanso Corporation Company Details Table Urenco Limited Company Details Table Rotem Industries, Ltd., Inc. Company Details Table Australian Nuclear Association And Technology Organization (ANSTO) Company Details Table Board of Radiation And Isotope Technology (BRIT) Company Details Table Institute of Atomic Energy Polatom Radioisotope Centre Company Details Table Institute of Isotopes Co., Ltd. Company Details Table Institute Of Radioelement (IRE) Company Details Table Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Regions 2019-2025 (K Units) Table Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Regions 2019-2025 Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast by Regions 2019-2025 Table Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Product 2019-2025 (K Units) Table Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Product 2019-2025 Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Product 2019-2025 (Million US$) Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast by Product 2019-2025 Table Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by End User 2019-2025 (K Units) Table Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by End User 2019-2025 Figure North America Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Radiopharmaceuticals in Nuclear Medicine Value Chain Table Radiopharmaceuticals in Nuclear Medicine Customers List Table Radiopharmaceuticals in Nuclear Medicine Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Bracco Imaging S.P.A. Cambridge Isotope Laboratories, Inc. Cardinal Health, Inc. Covidien, Plc Eczacibasi-Monrol Fujifilm Holdings Corporation GE Healthcare (Subsidiary Of General Electric Company) IBA Group Isotec, Inc. (Sigma-Aldrich) Lantheus Medical Imaging, Inc. Nordion, Inc. Ntp Radioisotopes (Pty), Ltd. Siemens Healthcare (Subsidiary Of Siemens AG) Taiyo Nippon Sanso Corporation Urenco Limited Rotem Industries, Ltd., Inc. Australian Nuclear Association And Technology Organization (ANSTO) Board of Radiation And Isotope Technology (BRIT) Institute of Atomic Energy Polatom Radioisotope Centre Institute of Isotopes Co., Ltd. Institute Of Radioelement (IRE)